Treatment with α-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive

Journal of Immunology

Volumn 168, Issue 11, 2002, Pages 5778-5785

  Duthie, Malcolm S ^a   Kahn, Stuart J ^a  

^a INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INFECTION CONTROL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; WEIGHT GAIN;

EID: 0036604214     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.11.5778     Document Type: Article

References (42)

1. Control of Chagas disease
2. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas' disease
3. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice
4. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein
5. Natural T cells: Cells that co-express NKRP-1 and TCR
6. NKT cells: Facts, functions and fallacies
7. Recognition and function of Vα14 NKT cells
8. Rapid death and regeneration of NKT cells in anti-CD3ε- or IL-12-treated mice: A major role for bone marrow in NKT cell homeostasis
9. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
10. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
11. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
12. + effector function against intracellular infection
13. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major
14. + TCRαβ intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro
15. Selective reduction of Vα14-NK T cells associated with disease development in autoimmune-prone mice
16. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
17. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
18. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans
19. α-galactosylceramide-activated Vα14 natural kilter T cells mediate protection against murine malaria
20. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
21. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes
22. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
23. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
24. Antigenic polymorphism of Trypanosoma cruzi: Clonal analysis of trypomastigote surface antigens
25. Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for β-galactosidase
26. A method for counting and concentrating living Trypanosoma cruzi in blood lysed with aminonium chloride
27. The major 85-kDa surface antigen of the mammalian-stage forms of Trypanosoma cruzi is a family of sialidases
28. Endogenous interferon-γ, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi
29. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice
30. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections
31. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes
32. Cutting edge: Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
33. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells
34. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
35. +NKT cells: Stimulation of IL-12 production by antigen-presenting cells in the innate immune system
36. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
37. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi
38. Tumor necrosis factor α-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice
39. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the Therapeutic potential of anti-IL-10 receptor antibody for sterile cure
40. The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-α, but not by anti-IL-6 or anti-IFN-γ antibodies
41. The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi